HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes
2010
HIV-2 Goes Global: An Unaddressed Issue in Indian Anti-Retroviral Programmes
Commentary
Author Information
Author(s): de Silva Thushan, Weiss Robin A.
Primary Institution: MRC/UCL Centre for Medical Molecular Virology, Division of Infection & Immunity, University College London
Conclusion
HIV-2 infection is not as widespread as HIV-1, but it still poses significant challenges for diagnosis and treatment in India.
Supporting Evidence
- HIV-2 and HIV-1/2 dual infections are prevalent in patients requiring ART in India.
- The lack of discriminatory diagnosis for these infections in national testing algorithms is concerning.
- Treatment options for HIV-2 are limited due to its resistance to certain medications.
Takeaway
HIV-2 is a type of HIV that is less common than HIV-1, but people with it still need good medical care. In India, doctors are not always able to tell the difference between HIV-1 and HIV-2, which can make treatment harder.
Limitations
The study highlights the lack of accurate diagnostic algorithms for HIV-2 in India and the limited evidence base for treatment options.
Want to read the original?
Access the complete publication on the publisher's website